A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Drug Toxicology Monitoring Tapentadol, Quantitative, Urine
Test Code91562
CPT Codes
80372 (HCPCS: G0480)
Preferred Specimen
3 mL urine submitted in a plastic, leak-proof container
Minimum Volume
2 mL
Other Acceptable Specimens
Urine collected in urine collection container
Transport Temperature
Room temperature
Specimen Stability
Room temperature: 5 days
Refrigerated: 7 days
Frozen: 30 days
Refrigerated: 7 days
Frozen: 30 days
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Non-urine samples • Urine containing preservatives
Methodology
Mass Spectrometry (MS)
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Set up: Daily; Report available: 3 days
Reference Range
<50 ng/mL
Clinical Significance
The purpose of this test is to determine the presence of Tapentadol and N-Desmethyltapentadol (metabolite) in urine. The results of this test are used in specific therapeutic treatment programs and Pain Management settings to determine compliance with prescribed dosing schedules.
Performing Laboratory
Quest Diagnostics Nichols Institute
14225 Newbrook Drive
Chantilly, VA 20153